Alternatively, sEVs loaded with a combination of anti-VEGF drugs and a nano dose of a clinically established long-acting anti-inflammatory drug could help to reduce the inflammation following intravitreal injection in diabetic retinopathy. The gene discussed is VEGFA; the disease is diabetic retinopathy.